Order Fluctuations Due to Product Life Cycles and Model Changes
First written in FY2016. 17 of 26 entries say "Restated". Latest entry: FY2026-H1.
Oriental Chain Mfg. moved to the "Worse" side of this theme in 2016.
0 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「During the interim consolidated accounting period under review, there were no new business and other risks, changes to such risks, or material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there were no material changes to existing risks, including the risk of order fluctuations due to product life cycles and model changes. - FY2024MaterialisedAnnual report
「Although the company is conducting sales activities aimed at expanding orders, primarily in the medical equipment sector, spot orders from the automotive industry have disappeared.」
In connection with order fluctuations due to product life cycles, model changes and other factors, the disappearance of spot orders from the automotive industry was also confirmed for the full fiscal year. - FY2024-Q2MaterialisedAnnual report
「Although the company is conducting sales activities aimed at expanding orders, primarily in the medical equipment sector, spot orders from the automotive industry have disappeared.」
The disappearance of spot orders from the automotive industry has continued, indicating that events related to risks involving product life cycles and order fluctuations are ongoing. - FY2024-Q1MaterialisedAnnual report
「Although the company is conducting sales activities aimed at expanding orders, primarily in the medical equipment sector, spot orders from the automotive industry have disappeared.」
The company states that spot orders from the automotive industry have disappeared in connection with risks related to product life cycles and order fluctuations. - FY2023-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no new business and other risks, changes to such risks, or material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there were no material changes to existing risks, including the risk of order fluctuations due to product life cycles and model changes. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no new business and other risks, changes to such risks, or material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there were no material changes to existing risks, including the risk of order fluctuations associated with product life cycles and model changes. - FY2022RestatedAnnual report
「Although the products in the metal injection molding business have gained traction, orders for these products may fluctuate significantly because of their short product life cycles and frequent model changes.」
The company reconfirms the risk of order fluctuations due to the short life cycles and frequent model changes of metal injection molding products. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no new business and other risks, changes to such risks, or material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there were no material changes to existing risks, including the risk of order fluctuations associated with product life cycles and model changes. - FY2022-Q1RestatedAnnual report
「During the cumulative first quarter, there were no new business or other risks and no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there were no material changes to existing risks, including the risk of order fluctuations associated with product life cycles and model changes. - FY2021RestatedAnnual report
「Although the products in the metal injection molding business have gained traction, orders for these products may fluctuate significantly because of their short product life cycles and frequent model changes.」
The company reconfirms the risk of order fluctuations due to the short life cycles and frequent model changes of metal injection molding products. - FY2021-Q3RestatedAnnual report
「The following matters arose during the cumulative third quarter under review: new business and other risks, changes to such risks, or material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk change specifically identified in this filing concerns listing standards, and no specific change is described regarding the risk of order fluctuations due to product life cycles or model changes. - FY2021-Q2RestatedAnnual report
「The following matters arose during the cumulative second quarter under review: new business and other risks, changes to such risks, or material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk change specifically identified in this filing concerns listing standards, and no specific change is described regarding the risk of order fluctuations due to product life cycles or model changes. - FY2020-Q3RestatedAnnual report
「During the nine months ended the third quarter, there were no new business or other risks and no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there were no material changes to existing risks, including the risk of order fluctuations associated with product life cycles and model changes. - FY2020-Q2RestatedAnnual report
「During the cumulative second-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」
The company states that there were no material changes to existing risks, including the risk of order fluctuations associated with product life cycles and model changes. - FY2020-Q1RestatedAnnual report
「During the cumulative first quarter, there were no new business or other risks and no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there were no material changes to existing risks, including the risk of order fluctuations associated with product life cycles and model changes. - FY2019RestatedAnnual report
「Although the products in the metal injection molding business have gained traction, orders for these products may fluctuate significantly because of their short product life cycles and frequent model changes.」
The company reconfirms the risk of significant fluctuations in orders for metal injection molding products due to their short product life cycles and frequent model changes. - FY2019-Q3RestatedAnnual report
「During the nine months ended the third quarter, there were no new business or other risks and no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there were no material changes to existing risks, including the risk of order fluctuations associated with product life cycles and model changes. - FY2019-Q2RestatedAnnual report
「During the cumulative second-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」
The company states that there were no material changes to existing risks, including the risk of order fluctuations associated with product life cycles and model changes. - FY2019-Q1RestatedAnnual report
「During the cumulative first quarter, there were no new business or other risks and no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there were no material changes to existing risks, including the risk of order fluctuations associated with product life cycles and model changes. - FY2018MaterialisedAnnual report
「In the Metal Injection Molding Business, we worked to expand orders, mainly in the medical-equipment field, but sales of automotive parts declined significantly due to model changes. As a result, net sales were ¥179 million, down 28.7% year on year, and operating profit was ¥18 million, down 46.0%.」
The decline in automotive component sales due to model changes also occurred over the full fiscal year, resulting in lower sales and operating profit in the metal injection molding business. - FY2018-Q3MaterialisedAnnual report
「Although we worked to expand orders, mainly in the medical-equipment field, sales of automotive parts declined significantly due to model changes. As a result, net sales were ¥123 million, down 41.7% year on year, and operating profit was ¥10 million, down 72.9%.」
The decline in automotive component sales associated with model changes continued, with sales in the metal injection molding business down 41.7% and operating profit down 72.9%. - FY2018-Q2MaterialisedAnnual report
「Although we worked to expand orders, mainly in the medical-equipment field, sales of automotive parts declined significantly due to model changes. As a result, net sales were ¥75 million, down 43.2% year on year, and operating profit was ¥4 million, down 81.1%.」
The decline in automotive component sales due to model changes continued, with sales in the metal injection molding business down 43.2% and operating profit down 81.1%. - FY2018-Q1MaterialisedAnnual report
「Although we worked to expand orders, mainly in the medical-equipment field, sales of automotive parts declined significantly due to model changes. As a result, net sales were ¥39 million, down 40.3% year on year, and operating profit was ¥4 million, down 66.3%.」
The decline in automotive component sales due to model changes recurred, with sales in the metal injection molding business down 40.3% and operating profit down 66.3%. - FY2017MaterialisedAnnual report
「Although we worked to expand orders, mainly in the medical-equipment field, sales of automotive parts declined significantly due to model changes. As a result, net sales were ¥252 million, down 8.9% year on year, and operating profit was ¥35 million, down 32.6%.」
Sales of automotive components actually declined due to model changes, resulting in lower sales and operating profit in the metal injection molding business. - FY2017-Q3RestatedAnnual report
「During the nine months ended the third quarter, there were no new business or other risks and no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there were no material changes to the business and other risks described in the previous fiscal year, and that the risk of order fluctuations associated with product life cycles and model changes remains. - FY2016MaterialisedAnnual report
「The company worked to expand orders, primarily in the medical equipment sector, to offset the decline in orders for automotive components due to model changes. As a result, net sales were ¥276 million, down 1.4% year on year.」
The company states that orders for automotive components actually declined due to model changes, and that sales in the metal injection molding business declined 1.4% year on year.